journal article·2025-07

Zn2+, Sr2+, and Sm3+ tri-doped whitlockites: Luminescent materials with improved bioactive and antibacterial properties

Dina V. Deyneko, Vladimir N. Lebedev, Sergey M. Aksenov, Roman Yu Shendrik, Vladimir Pankratov, Bogdan I. Lazoryak, Alevtina N. Gosteva, Katia Barbaro, Julietta V. Rau

Ceramics International· Volume 51· Issue 16
Publisher page

Abstract

Tri-doped phosphates Ca8‒xSrxZnSm(PO4)7 with the β-Ca3(PO4)2 (whitlockite) structure have been synthesized using solid-state synthesis. The crystal structure evolution from whitlockite to strontiowhitlockite was observed with Ca2+ → Sr2+ substitution. X-ray powder diffraction and second optical harmonic generation methods confirmed the symmetry inhomogeneity in the series, revealing a change in space group from R3̅c to R3̅m. In the Ca8‒xSrxZnSm(PO4)7 hosts, Sm3+ ions exhibited intense red emission according to 4G5/2 → 6H7/2 and 4G5/2 → 6H9/2 transitions, coinciding with the biological window. The photoluminescence properties were study in detail, and the most intensive emission was found in sample with x = 3. All samples from the synthesized Ca8‒ xSrxZnSm(PO4)7 phosphate series showed high viability rates in aMSCs cell cultures compared to Journal Pre-proof 2 the control. The samples enhanced the osteogenic differentiation potential of aMSCs without significant differences depending on the Sr2+ concentration. The antimicrobial activity was study on five microorganisms: S. aureus, E. coli, P. aeruginosa, E. faecalis and C. albicans. All phosphate samples effectively inhibited bacterial growth, with samples x = 6 and 7.5 showing the highest effectiveness. The antimicrobial activity results from the synergistic effect of Ca2+, Sr2+ , Zn2+, and Sm3+ ions released into the solution at acceptable pH values. The study shows that both whitlockite and strontiowhitlockite structures can be considered as promising materials for bone substitutes, while the addition of the luminescent active Sm3+ ions will allow their use for bioimaging.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Luminescence Properties of Advanced Materials · Pigment Synthesis and Properties · Crystal Structures and Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (71)

Show source-provided references
1. Targeted and theranostic applications for nanotechnologies in medicine
2. Locally applied TCP inhibits tumor growth via possible activation of macrophages10.1002/jbm.a.32367 ↗
3. Calcium phosphate bone cements as local drug delivery systems for bone cancer treatment10.1016/j.bioadv.2023.213367 ↗
4. Composite remineralization of bone-collagen matrices by low-temperature ceramics and Serum albumin: a new approach to the creation of highly effective osteoplastic materials10.3390/jfb15020027 ↗
5. Neodymium and manganese ions Co-doped whitlockite for temperature monitoring, photothermal therapy, and bone tissue repair in osteosarcoma10.1016/j.jcis.2023.09.186 ↗
6. Enhanced in vitro inhibition of MCF-7 and magnetic properties of cobalt incorporated calcium phosphate (HAp and β-TCP) nanoparticles10.1016/j.ceramint.2022.09.058 ↗
7. DNA aptamer functionalized monodisperse Eu/Mn-wh nanoparticle for in vivo magnetic resonance and fluorescence imaging10.1016/j.ceramint.2023.11.046 ↗
8. Bone mineral: new insights into its chemical composition10.1038/s41598-019-44620-6 ↗
9. Antimicrobial activity of ion-substituted calcium phosphates: a systematic review10.1016/j.heliyon.2023.e16568 ↗
10. The influence of strontium on bone tissue metabolism and its application in osteoporosis treatment10.3390/ijms22126564 ↗
11. Influence of synthesis conditions on gadolinium-substituted tricalcium phosphate ceramics and its physicochemical, biological, and antibacterial properties10.3390/nano12050852 ↗
12. Lanthanides and tissue engineering strategies for bone regeneration10.1016/j.ccr.2019.03.003 ↗
13. Lanthanides-substituted hydroxyapatite for biomedical applications10.3390/ijms24043446 ↗
14. In vitro and in vivo evaluation of whitlockite biocompatibility: comparative study with hydroxyapatite and β -tricalcium phosphate10.1002/adhm.201400824 ↗
15. Photoluminescence, structural and antibacterial properties of Co-doped β-Ca3(PO4)2-type phosphates Ca8CuRE(PO4)7 (RE = Eu–Er)10.1016/j.jre.2023.07.023 ↗
16. Simultaneous substitutions of Gd3+ and Dy3+ in β-Ca3(PO4)2 as a potential multifunctional bio-probe10.1016/j.matdes.2017.02.013 ↗
17. Tracking the local environment of Eu3+ in Eu3+-doped calcium phosphate during hydroxyapatite crystallization and its phase transformation to tricalcium phosphate10.1016/j.ceramint.2020.12.265 ↗
18. In vitro evaluation of samarium (III) oxide as a bone substituting material10.1002/jbm.a.32667 ↗
19. Biocompatibility and osteogenic activity of samarium-doped hydroxyapatite-biomimetic nanoceramics for bone regeneration applications10.3390/biomimetics9060309 ↗
20. Biocompatibility and antibiofilm properties of samarium doped hydroxyapatite coatings: an in vitro study10.3390/coatings11101185 ↗
21. Treatment of bone pain secondary to metastases using samarium-153-EDTMP10.1590/S1516-31802004000500006 ↗
22. Samarium enriches antitumor activity of ZnO nanoparticles via downregulation of CXCR4 receptor and cytochrome P45010.1177/1010428320909999 ↗
23. Samarium doped glass-reinforced hydroxyapatite with enhanced osteoblastic performance and antibacterial properties for bone tissue regeneration10.1039/C4TB00484A ↗
24. Microstructural analysis and antibacterial response of Zn2+/Mg2+ dual doped β-tricalcium phosphate bioceramics10.22146/ijc.72286 ↗
25. Dependence of antimicrobial properties on site-selective arrangement and concentration of bioactive Cu2+ ions in tricalcium phosphate10.1016/j.ceramint.2023.03.260 ↗
26. Hyperthermia effect and antibacterial efficacy of Fe3+/Co2+ Co‐substitutions in β‐Ca3(PO4)2 for bone cancer and defect therapy10.1002/jbm.b.33921 ↗
27. Synthesis, structure, thermal stability, mechanical and antibacterial behaviour of lanthanum (La3+) substitutions in β-tricalciumphosphate10.1016/j.msec.2014.07.054 ↗
28. Crystallographic studies of the role of Mg as a stabilizing impurity in β-Ca3(PO4)2. The crystal structure of pure β-Ca3(PO4)210.1016/0022-4596(74)90030-9 ↗
29. Design and processing of ZnO doped tricalcium phosphate based materials: influence of β/α polymorph phase assemblage on microstructural evolution10.1016/j.jeurceramsoc.2011.09.025 ↗
30. Thermally induced crystallization and phase evolution of amorphous calcium phosphate substituted with divalent cations having different sizes10.1021/acs.cgd.0c01534 ↗
31. An improvement in sintering property of β-tricalcium phosphate by addition of calcium pyrophosphate10.1016/S0142-9612(01)00201-0 ↗
32. Dissolution-precipitation synthesis and characterization of zinc whitlockite with variable metal content10.1021/acsbiomaterials.1c00335 ↗
33. Effects of zinc and strontium substitution in tricalcium phosphate on osteoclast differentiation and resorption10.1039/C2BM00012A ↗
34. Antimicrobial properties of Co-doped tricalcium phosphates Ca3-2x(MˊMˊˊ)x(PO4)2 (M = Zn2+, Cu2+, Mn2+ and Sr2+)10.1016/j.ceramint.2022.06.237 ↗
35. Synthesis and characterization of strontium-substituted hydroxyapatite nanoparticles for bone regeneration10.1016/j.msec.2016.10.047 ↗
36. Strontium-doped hydroxyapatite and its role in osteogenesis and angiogenesis10.1387/ijdb.230091lc ↗
37. Site occupancy, luminescence and dielectric properties of β-Ca3(PO4)2-type Ca8ZnLn(PO4)7 host materials10.1016/j.jallcom.2022.164521 ↗
38. Luminescence spectroscopy under synchrotron radiation: from SUPERLUMI to FINESTLUMI10.1016/j.nimb.2020.04.015 ↗
39. Time-resolved luminescence and excitation spectroscopy of Co-doped Gd3Ga3Al2O12 scintillating crystals10.1038/s41598-020-77451-x ↗
40. Sr8MSm1-хEuх(PO4)7 phosphors derived by different synthesis routes: solid state, sol-gel and hydrothermal, the comparison of properties10.1016/j.jallcom.2021.161340 ↗
41. Symmetry inhomogeneity of Ca9–xZnxEu(PO4)7 phosphor determined by second-harmonic generation and dielectric and photoluminescence spectroscopy10.1021/acs.cgd.0c00637 ↗
42. Crystal chemistry of the noncentrosymmetric eulytites: A3Bi(XO4)3 (X = V, A = Pb; X = P, A = Ca, Cd, Sr, Pb)10.1021/ic101316u ↗
43. Calcium-to-Phosphorus releasing ratio affects osteoinductivity and osteoconductivity of calcium phosphate bioceramics in bone tissue engineering10.1186/s12938-023-01067-1 ↗
44. Enhanced release of calcium ions from hydroxyapatite nanoparticles with an increase in their specific surface area10.3390/ma16196397 ↗
45. Evaluation of samarium doped hydroxyapatite, ceramics for medical application: antimicrobial activity10.1155/2015/849216 ↗
46. Strontiowhitlockite, Sr9Mg(PO3OH)(PO4)6, a new mineral from the kovdor deposit, kola peninsula
47. Iis sopyan low temperature hydrothermal synthesis of calcium phosphate ceramics: effect of excess Ca precursor on phase behavior
48. The infrared and Raman spectra of β-and α-tricalcium phosphate (Ca3(PO4)2)10.1080/00387019808007439 ↗
49. Thermographic properties of Eu3+ and Sm3+ doped Lu2O3 nanophosphor10.2298/JSC121021140L ↗
50. VUV–UV photoluminescence spectra of strontium orthophosphate doped with rare earth ions10.1016/S0022-4596(02)99651-9 ↗
51. Color tunable SrZrO3:Sm3+ nanopowders with satisfactory photoluminescent, band engineering properties for warm white LEDs and advanced forensic applications10.1016/j.molstruc.2021.132302 ↗
52. Energy transfer in oxidic phosphors10.1016/0375-9601(68)90486-6 ↗
53. Theory of concentration quenching in inorganic phosphors10.1063/1.1740265 ↗
54. Radiation-induced effects and valence changes of samarium ions in Sr3Sm(PO4)310.1149/1.3153142 ↗
55. Relationship of the different Ca sites in the matrix with luminescence properties of orange‒red emitting Li0.04Ca0.96–хSiO3:Smx phosphors10.1016/j.ceramint.2022.01.253 ↗
56. Synthesis and photoluminescence properties of Sr3(PO4)2:Re3+, Li+ (Re = Eu, Sm) red phosphors for white light-emitting diodes10.1016/j.ceramint.2017.05.174 ↗
57. Eu 2+ -activated Sr8ZnSc(PO4)7 : a novel near-ultraviolet converting yellow-emitting phosphor for white light-emitting diodes10.1021/am302014e ↗
58. Photoluminescence tuning of Ca8−xSrxMgGd(PO4)7 :Eu2+,yMn2+ phosphors for applications in white LEDs with excellent color rendering index10.1039/C6RA28594E ↗
59. Constructing a single-white-light emission by finely modulating the occupancy of luminescence centers in europium-doped (Ca1−xSrx)9Bi(PO4)7 for WLEDs10.1039/D0TC02467H ↗
60. Co-doping effect of Mn2+ and Eu3+ on luminescence in strontiowhitlockite phosphors10.3390/molecules29010124 ↗
61. New noncentrosymmetric vanadates Sr9R(VO4)7 (R = Tm, Yb, and Lu): synthesis, structure analysis, and characterization10.1021/cm048282f ↗
62. Dissolution mechanisms of β-tricalcium phosphate doped with monovalent metal ions10.2109/jcersj2.118.451 ↗
63. Resorbability and solubility of zinc-containing tricalcium phosphate10.1002/jbm.10068 ↗
64. Deynekoite, Ca9Fe3+(PO4)7 – a new mineral of the merrillite group from phosphide-bearing contact facies of paralava, hatrurim complex, daba-siwaqa, Jordan
65. Effect of Mn doping on the low-temperature synthesis of tricalcium phosphate (TCP) polymorphs10.1016/j.jeurceramsoc.2019.03.057 ↗
66. Synthesis and characterization of tricalcium phosphate with Zn and Mg based dopants10.1007/s10856-008-3395-4 ↗
67. The effect of strontium-substituted hydroxyapatite nanofibrous matrix on osteoblast proliferation and differentiation10.3390/membranes11080624 ↗
68. Antibacterial properties and regenerative potential of Sr2+ and Ce3+ doped fluorapatites; a potential solution for peri-implantitis10.1038/s41598-019-50916-4 ↗
69. Calcium‐dependent antimicrobials: nature‐inspired materials and designs10.1002/EXP.20230099 ↗
70. New antimicrobial strategies based on metal complexes
71. Gram positive and gram negative bacteria differ in their sensitivity to cold plasma10.1038/srep38610 ↗